共 50 条
- [41] Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B InhibitorJOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (21) : 6685 - 6706Pisani, LeonardoMuncipinto, GiovanniMiscioscia, Teresa FabiolaNicolotti, OrazioLeonetti, FrancescoCatto, MarcoCaccia, CarlaSalvati, PatriciaSoto-Otero, RamonMendez-Alvarez, EstefaniaPasseleu, CelineCarotti, Angelo
- [42] Design, synthesis of novel (Z)-2-(3-(4-((3-benzyl-2,4dioxothiazolidin-5-ylidene)methyl)-1-phenyl-1H-pyrazol-3-yl) phenoxy)-N-arylacetamide derivatives: Evaluation of cytotoxic activity and molecular docking studiesJOURNAL OF MOLECULAR STRUCTURE, 2020, 1202Kolluri, Prashanth KumarGurrapu, NirmalaSubhashini, N. J. P.Putta, ShravaniSingh, Surya SathyanarayanaVani, TamalapakulaManga, Vijjulatha
- [43] Novel inhibitor of p38 map kinase as an anti-TNF-&alpha drug:: Discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatic agent.ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U130 - U130Miwatashi, SArikawa, YKotani, EMiyamoto, MNaruo, KKimura, HTanaka, TAsahi, SOhkawa, S
- [44] Novel inhibitor of p38 MAP kinase as an anti-TNF-α drug:: Discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agentJOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (19) : 5966 - 5979Miwatashi, SArikawa, YKotani, EMiyamoto, MNaruo, KKimura, HTanaka, TAsahi, SOhkawa, S
- [45] Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting ActivityJOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (03) : 1203 - 1217Nirogi, RamakrishnaShinde, AnilMohammed, Abdul RasheedBadange, Rajesh KumarReballi, VeenaBandyala, Thrinath ReddySaraf, Sangram KeshariBojja, KumarManchineella, SravanthiAchanta, Pramod KumarKandukuri, Kiran KumarSubramanian, RamkumarBenade, VijayPalacharla, Raghava ChoudaryJayarajan, PradeepPandey, SantoshkumarJasti, Venkat
- [46] The Discovery of N-((2H-Tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): A Potent and Selective Glucagon Receptor AntagonistJOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2601 - 2610DeMong, DuaneDai, XingHwa, JoyceMiller, MichaelLin, Sue-IngKang, LingStamford, AndrewGreenlee, WilliamYu, WenshengWong, MichaelLavey, BrianKozlowski, JosephZhou, GuoweiYang, De-YiPatel, BhuneshwariSoriano, AileenZhai, YingSondey, ChristopherZhang, HongtaoLachowicz, JeanGrotz, DianeCox, KathleenMorrison, RichardAndreani, TeresaCao, YangLiang, MarkMeng, TaoMcNamara, PaulWong, JesseBradley, PrudenceFeng, Kung-IBelani, JitendraChen, PingDai, PengGauuan, JoliciaLin, PeishanZhao, He
- [47] Piperazine-based CCR5 antagonists as HIV-1 inhibitors.: II.: Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4-methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro-methyl)phenyl]ethyl]-1-piperazinyl]-piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonistJOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (21) : 3343 - 3346Tagat, JRSteensma, RWMcCombie, SWNazareno, DVLin, SINeustadt, BRCox, KXu, SWojcik, LMurray, MGVantuno, NBaroudy, BMStrizki, JM
- [48] Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for neuropeptide YY5 receptorJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (02): : 562 - 570Kakui, NTanaka, JTabata, YAsai, KMasuda, NMiyara, TNakatani, YOhsawa, FNishikawa, NSugai, MSuzuki, MAoki, KKitaguchi, H
- [49] Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesityBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6797 - 6801Elliott, Richard L.Cameron, Kimberly O.Chin, Janice E.Bartlett, Jeremy A.Beretta, Elena E.Chen, YueJardine, Paul Da SilvaDubins, Jeffrey S.Gillaspy, Melissa L.Hargrove, Diane M.Kalgutkar, Amit S.LaFlamme, Janet A.Lame, Mary E.Martin, Kelly A.Maurer, Tristan S.Nardone, Nancy A.Oliver, Robert M.Scott, Dennis O.Sun, DexueSwick, Andrew G.Trebino, Catherine E.Zhang, Yingxin
- [50] Structure-activity relationships of a novel class of endothelin-A receptor antagonists and discovery of potent and selective receptor antagonist, 2-(benzo[1,3]dioxol-5-yl)-6-isopropyloxy-4-(4-methoxyphenyl)-2H-chromene-3-carboxylic acid (S-1255).: 1.: Study on structure-activity relationships and basic structure crucial for ETA antagonismJOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (10) : 2041 - 2055Ishizuka, NMatsumura, KSakai, KFujimoto, MMihara, SYamamori, T